Regional Workshop from 10 to 12 April 2017, N’Diambour Hotel, Dakar, Senegal

on technology transfer and public health

This workshop was organized in collaboration with the Government of the Republic of Senegal, UNCTAD, UNDP and UNAIDS.
The general objective is to promote the creation of a legal framework conducive to the supply of generic medicines and the acquisition of a technological base necessary for local drug production projects.

The participants were the directors of the Pharmacy, Medicine and Laboratories departments (DPML) of the Ministry of Health, the directors of the National Liaison Services with the African Intellectual Property Organization (OAPI) who are under the authority of the Ministry of Industry and Trade. They came from Burkina Faso, Cameroon, Ivory Coast, Mali, Niger and Senegal.

The meeting focused on the following points:

1. Preconditions for technology transfers in the pharmaceutical field;
2. The practical implementation of the transitional period obtained on 6 November 2015 following the decision of the TRIPS Council in favor of LDCs;
3. The introduction to the examination of the criteria of patentability;
4. The recommendations of the UN Secretary-General’s High Level Group on Access to Medicines;
5. The launch of the concept of “Interministerial Commission dedicated to access to medicines and the promotion of pharmaceutical innovation”.

To find out more:

• The workshop in the Senegalese media
Final report

November 23, 2015 Workshop, UNAIDS, Geneva, Switzerland

The TRIPS Agreement, the Doha Declaration on TRIPS and Public Health, the Bangui Agreement, and access to medicines.

This symposium brought together various experts as well as the directors of the national liaison services with OAPI, diplomats from French-speaking African countries at the UN in Geneva, directors in charge of pharmacy, medicine and laboratories from West Africa and civil society physicians. The objective was to analyze barriers to access to medicines in the least developed countries of Africa and to present recommendations for action.

The meeting focused on the following points:

  • Flexibilities of the TRIPS Agreement (1999) of the World Trade Organization (WTO)
  • The 6 November 2015 decision of the TRIPS Council on the extension of the transitional period
  • The 1999 Revised Bangui Agreement by the African Intellectual Property Organization (OAPI)
  • The local production of generics in French-speaking countries in West and Central Africa

To find out more: